A recent study aimed to analyze the healthcare resource use and costs associated with patients suffering from Hemophilia A and B in France. The study utilized a nationwide claims database to gather data, as there is limited information available on this topic. This analysis is crucial for understanding the economic burden and healthcare needs of patients with these conditions.
The study's focus on healthcare resource use and costs highlights the importance of managing Hemophilia effectively. By examining the data from a nationwide claims database, researchers can better understand how to optimize care and reduce costs for patients with Hemophilia A and B in France. This type of research is essential for improving patient outcomes and reducing the economic impact of these conditions on the healthcare system (Frenzel et al., 2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: